These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32601926)

  • 1. Organization Communication Factors and Abnormal Mammogram Follow-up: a Qualitative Study Among Ethnically Diverse Women Across Three Healthcare Systems.
    Kenny JD; Karliner LS; Kerlikowske K; Kaplan CP; Fernandez-Lamothe A; Burke NJ
    J Gen Intern Med; 2020 Oct; 35(10):3000-3006. PubMed ID: 32601926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the patient-provider communication needs and experiences of Latina and non-Latina White women following an abnormal mammogram.
    Molina Y; Hohl SD; Ko LK; Rodriguez EA; Thompson B; Beresford SA
    J Cancer Educ; 2014 Dec; 29(4):781-9. PubMed ID: 24748097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up of abnormal screening mammograms among low-income ethnically diverse women: findings from a qualitative study.
    Allen JD; Shelton RC; Harden E; Goldman RE
    Patient Educ Couns; 2008 Aug; 72(2):283-92. PubMed ID: 18490127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial/ethnic disparities in time to follow-up after an abnormal mammogram.
    Press R; Carrasquillo O; Sciacca RR; Giardina EG
    J Womens Health (Larchmt); 2008; 17(6):923-30. PubMed ID: 18554094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in abnormal mammogram follow-up time for Asian women compared with non-Hispanic white women and between Asian ethnic groups.
    Nguyen KH; Pasick RJ; Stewart SL; Kerlikowske K; Karliner LS
    Cancer; 2017 Sep; 123(18):3468-3475. PubMed ID: 28603859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic differences in social support after initial receipt of an abnormal mammogram.
    Molina Y; Hohl SD; Nguyen M; Hempstead BH; Weatherby SR; Dunbar C; Beresford SA; Ceballos RM
    Cultur Divers Ethnic Minor Psychol; 2016 Oct; 22(4):588-593. PubMed ID: 27213509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversations about Abnormal Mammograms on Distress and Timely Follow-up Across Ethnicity.
    Molina Y; Beresford SAA; Hayes Constant T; Thompson B
    J Cancer Educ; 2017 Jun; 32(2):320-327. PubMed ID: 26403889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammography facilities serving vulnerable women have longer follow-up times.
    Karliner LS; Kaplan C; Livaudais-Toman J; Kerlikowske K
    Health Serv Res; 2019 Feb; 54 Suppl 1(Suppl 1):226-233. PubMed ID: 30394526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multilevel Factors Associated With Time to Biopsy After Abnormal Screening Mammography Results by Race and Ethnicity.
    Lawson MB; Bissell MCS; Miglioretti DL; Eavey J; Chapman CH; Mandelblatt JS; Onega T; Henderson LM; Rauscher GH; Kerlikowske K; Sprague BL; Bowles EJA; Gard CC; Parsian S; Lee CI
    JAMA Oncol; 2022 Aug; 8(8):1115-1126. PubMed ID: 35737381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Language barriers, location of care, and delays in follow-up of abnormal mammograms.
    Karliner LS; Ma L; Hofmann M; Kerlikowske K
    Med Care; 2012 Feb; 50(2):171-8. PubMed ID: 21993060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Mixed Method Approach to Examine Surveillance Mammography Experiences in Black and White Breast Cancer Survivors.
    Edmonds MC; Kim SJ; Wells M; Dahman B; Sheppard VB
    Clin Breast Cancer; 2022 Dec; 22(8):801-811. PubMed ID: 36137937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological Outcomes After a False Positive Mammogram: Preliminary Evidence for Ethnic Differences Across Time.
    Molina Y; Beresford SA; Thompson B
    J Racial Ethn Health Disparities; 2017 Apr; 4(2):123-133. PubMed ID: 26896036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delays in Follow-up Care for Abnormal Mammograms in Mobile Mammography Versus Fixed-Clinic Patients.
    Vang SS; Dunn A; Margolies LR; Jandorf L
    J Gen Intern Med; 2022 May; 37(7):1619-1625. PubMed ID: 35212876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to Clinical Follow-up after Abnormal Mammogram among African American and Hispanic Women.
    Petersen SS; Sarkissyan M; Wu Y; Clayton S; Vadgama JV
    J Health Care Poor Underserved; 2018; 29(1):448-462. PubMed ID: 29503311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Travel distance to screening facilities and completion of abnormal mammographic follow-up among disadvantaged women.
    Khang L; Adams SA; Steck SE; Zhang J; Xirasagar S; Daguise VG
    Ann Epidemiol; 2017 Jan; 27(1):35-41. PubMed ID: 27729181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate and Timeliness of Diagnostic Evaluation and Biopsy After Recall From Screening Mammography in the National Mammography Database.
    Oluyemi ET; Grimm LJ; Goldman L; Burleson J; Simanowith M; Yao K; Rosenberg RD
    J Am Coll Radiol; 2024 Mar; 21(3):427-438. PubMed ID: 37722468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial and ethnic differences in mammography use among U.S. women younger than age 40.
    Kapp JM; Ryerson AB; Coughlin SS; Thompson TD
    Breast Cancer Res Treat; 2009 Jan; 113(2):327-37. PubMed ID: 18264758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceived discrimination is associated with reduced breast and cervical cancer screening: the Study of Women's Health Across the Nation (SWAN).
    Jacobs EA; Rathouz PJ; Karavolos K; Everson-Rose SA; Janssen I; Kravitz HM; Lewis TT; Powell LH
    J Womens Health (Larchmt); 2014 Feb; 23(2):138-45. PubMed ID: 24261647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up among women with an abnormal mammogram in an HMO: is it complete, timely, and efficient?
    Burack RC; Simon MS; Stano M; George J; Coombs J
    Am J Manag Care; 2000 Oct; 6(10):1102-13. PubMed ID: 11184666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.